NM_024503.5:c.7015A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024503.5(HIVEP3):​c.7015A>G​(p.Thr2339Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.994 in 1,533,770 control chromosomes in the GnomAD database, including 757,851 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 71866 hom., cov: 32)
Exomes 𝑓: 1.0 ( 685985 hom. )

Consequence

HIVEP3
NM_024503.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.588

Publications

19 publications found
Variant links:
Genes affected
HIVEP3 (HGNC:13561): (HIVEP zinc finger 3) This gene encodes a member of the human immunodeficiency virus type 1 enhancer-binding protein family. Members of this protein family contain multiple zinc finger and acid-rich (ZAS) domains and serine-threonine rich regions. This protein acts as a transcription factor and is able to regulate nuclear factor kappaB-mediated transcription by binding the kappaB motif in target genes. This protein also binds the recombination signal sequence that flanks the V, D, and J regions of immunoglobulin and T-cell receptors. Alternate splicing results in both coding and non-coding transcript variants. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3137944E-6).
BP6
Variant 1-41510657-T-C is Benign according to our data. Variant chr1-41510657-T-C is described in ClinVar as Benign. ClinVar VariationId is 402941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HIVEP3NM_024503.5 linkc.7015A>G p.Thr2339Ala missense_variant Exon 9 of 9 ENST00000372583.6 NP_078779.2 Q5T1R4-1
HIVEP3NM_001127714.3 linkc.7012A>G p.Thr2338Ala missense_variant Exon 8 of 8 NP_001121186.1 Q5T1R4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HIVEP3ENST00000372583.6 linkc.7015A>G p.Thr2339Ala missense_variant Exon 9 of 9 1 NM_024503.5 ENSP00000361664.1 Q5T1R4-1

Frequencies

GnomAD3 genomes
AF:
0.971
AC:
147672
AN:
152118
Hom.:
71818
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.901
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.988
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.978
GnomAD2 exomes
AF:
0.993
AC:
139881
AN:
140928
AF XY:
0.994
show subpopulations
Gnomad AFR exome
AF:
0.890
Gnomad AMR exome
AF:
0.994
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.993
GnomAD4 exome
AF:
0.996
AC:
1376544
AN:
1381534
Hom.:
685985
Cov.:
72
AF XY:
0.997
AC XY:
677562
AN XY:
679732
show subpopulations
African (AFR)
AF:
0.892
AC:
27965
AN:
31354
American (AMR)
AF:
0.993
AC:
34802
AN:
35040
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
24507
AN:
24510
East Asian (EAS)
AF:
1.00
AC:
35566
AN:
35566
South Asian (SAS)
AF:
1.00
AC:
78167
AN:
78180
European-Finnish (FIN)
AF:
1.00
AC:
43817
AN:
43820
Middle Eastern (MID)
AF:
0.987
AC:
4589
AN:
4650
European-Non Finnish (NFE)
AF:
0.999
AC:
1070471
AN:
1071254
Other (OTH)
AF:
0.991
AC:
56660
AN:
57160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
295
590
885
1180
1475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21270
42540
63810
85080
106350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.971
AC:
147778
AN:
152236
Hom.:
71866
Cov.:
32
AF XY:
0.972
AC XY:
72340
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.901
AC:
37404
AN:
41528
American (AMR)
AF:
0.988
AC:
15120
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3469
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5158
AN:
5158
South Asian (SAS)
AF:
0.999
AC:
4813
AN:
4816
European-Finnish (FIN)
AF:
1.00
AC:
10626
AN:
10626
Middle Eastern (MID)
AF:
0.990
AC:
291
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67919
AN:
68018
Other (OTH)
AF:
0.978
AC:
2066
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
219
438
658
877
1096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.987
Hom.:
13008
Bravo
AF:
0.967
TwinsUK
AF:
0.999
AC:
3705
ALSPAC
AF:
0.999
AC:
3849
ESP6500AA
AF:
0.915
AC:
3684
ESP6500EA
AF:
0.997
AC:
7782
ExAC
AF:
0.981
AC:
87682
Asia WGS
AF:
0.991
AC:
3446
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

HIVEP3-related disorder Benign:1
Apr 30, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.22
DANN
Benign
0.13
DEOGEN2
Benign
0.053
.;T;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0034
N
LIST_S2
Benign
0.18
.;T;T
MetaRNN
Benign
0.0000013
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.63
.;N;.
PhyloP100
0.59
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.17
.;N;N
REVEL
Benign
0.042
Sift
Benign
1.0
.;T;T
Sift4G
Benign
1.0
.;T;T
Polyphen
0.0
B;B;B
Vest4
0.022, 0.015
MPC
0.18
ClinPred
0.00068
T
GERP RS
2.2
Varity_R
0.027
gMVP
0.043
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9439043; hg19: chr1-41976328; COSMIC: COSV56011601; API